Enhanced activity of pSTAT-3 ser-727 in functional endothelial cells under calcifying conditions

Current Chemical Biology

Volumn 4, Issue 2, 2010, Pages 133-144

  Mendoza Rincón, Jorge Flavio ^a   González Robles, Arturo ^b   López Marure, Rebeca ^c   Cáceres Cortés, Julio Roberto ^d  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

5 aza 2' deoxycytidine; Alkaline phosphatase; Autophagy; STAT3; Vascular calcification

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ALKALINE PHOSPHATASE; CALCIUM; SERINE; STAT3 PROTEIN;

BLOOD VESSEL CALCIFICATION; CALCIUM CELL LEVEL; CELL DEATH; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; UMBILICAL VEIN;

EID: 77951608885     PISSN: 18723136     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231310791170766     Document Type: Review

References (78)

1. Levy DE, Lee CK. What does Stat3 do? J Clin Invest 2002; 109: 1143-1148
2. Akira S. Roles of STAT3 defined by tissue-specific gene targeting. Oncogene 2000; 19: 2607-2611 (Pubitemid 30339216)
3. Bromberg J. Stat proteins and oncogenesis. J Clin Invest 2002; 109: 1139-1142
4. Bromberg JF, Wrzeszczynska MH, Devgan G, et al. Stat3 as an oncogene. Cell 1999; 98: 295-303.
5. Bode JG, Schweigart J, Kehrmann J, et al. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex. J Immunol 2003; 171: 257-266 (Pubitemid 36745296)
6. Schuringa JJ, Schepers H, Vellenga E, Kruijer W. Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation. FEBS Lett 2001; 495: 71-76 (Pubitemid 32367976)
7. Janjua S, Stephanou A, Latchman DS. The C-terminal activation domain of the STAT-1 transcription factor is necessary and sufficient for stress-induced apoptosis. Cell Death Differ 2002; 9: 1140-1146
8. Takeda K, Noguchi K, Shi W, et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 1997; 94: 3801-3804 (Pubitemid 27180453)
9. Chapman RS, Lourenco P, Tonner E, et al. The role of Stat3 in apoptosis and mammary gland involution. Conditional deletion of Stat3. Adv Exp Med Biol 2000; 480: 129-138 (Pubitemid 32176103)
10. Kawashima T, Bao YC, Nomura Y, et al. Rac1 and a GTPase-activating protein, MgcRacGAP, are required for nuclear translocation of STAT transcription factors. J Cell Biol 2006; 175: 937-946 (Pubitemid 44969199)
11. Dabir S, Kluge A, Dowlati A. The association and nuclear translocation of the PIAS3-STAT3 complex is ligand and time dependent. Mol Cancer Res 2009; 7: 1854-1860
12. Soto-Cruz I, Rangel-Corona R, Valle-Mendiola A, et al. The tyrphostin B42 inhibits cell proliferation and HER-2 autophosphorylation in cervical carcinoma cell lines. Cancer Invest 2008; 26: 136-144 (Pubitemid 351225460)
13. Kiuchi N, Nakajima K, Ichiba M, et al. STAT3 is required for the gp130-mediated full activation of the c-myc gene. J Exp Med 1999; 189: 63-73. (Pubitemid 29047027)
14. Ivanov VN, Bhoumik A, Krasilnikov M, et al. Cooperation between STAT3 and c-jun suppresses Fas transcription. Mol Cell 2001; 7: 517-528 (Pubitemid 32706344)
15. Aoki Y, Feldman GM, Tosato G. Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood 2003; 101: 1535-1542 (Pubitemid 36182531)
16. Calò V, Migliavacca M, Bazan V, et al. STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 2003; 197: 157-168 (Pubitemid 37485244)
17. Chapman RS, Lourenco PC, Tonner E, et al. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev 1999; 13: 2604-2616 (Pubitemid 29489651)
18. Zhao L, Melenhorst JJ, Hennighausen L. Loss of interleukin 6 results in delayed mammary gland involution: a possible role for mitogen-activated protein kinase and not signal transducer and activator of transcription 3. Mol Endocrinol 2002; 16: 2902-2912 (Pubitemid 36024180)
19. Lee CK, Raz R, Gimeno R, et al. STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity 2002; 17: 63-72. (Pubitemid 34874619)
20. Xie W, Su K, Wang D, Paterson AJ, Kudlow JE. MDA468 growth inhibition by EGF is associated with the induction of the cyclin-dependent kinase inhibitor p21WAF1. Anticancer Res 1997; 17: 2627-2633 (Pubitemid 27352664)
21. de la Iglesia N, Konopka G, Puram SV, et al. Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway Genes Dev 2008; 22: 449-462
22. Sansom O. Tissue-specific tumour suppression by APC. Adv Exp Med Biol 2009; 65: 6107-6118
23. Sansom OJ, Meniel VS, Muncan V, et al. Myc deletion rescues Apc deficiency in the small intestine. Nature 2007; 446: 676-679 (Pubitemid 46606884)
24. Wen Z, Zhong Z, Darnell JE, Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995; 82: 241-250
25. Blüthgen N, Legewie S. Systems analysis of MAPK signal transduction. Essays Biochem 2008; 45: 95-107.
26. Platanias LC. The p38 mitogen-activated protein kinase pathway and its role in interferon signaling. Pharmacol Ther 2003; 98: 129-142
27. Chung J, Uchida E, Grammer TC, Blenis J. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol 1997; 17: 6508-6516 (Pubitemid 27451197)
28. Lee HK, Jung J, Lee SH, Seo SY, Suh DJ, Park HT. Extracellular Signal-regulated Kinase Activation Is Required for Serine 727 Phosphorylation of STAT3 in Schwann Cells in vitro and in vivo. Korean J Physiol Pharmacol 2009; 13: 161-168
29. Zhu X, Wen Z, Xu LZ, Darnell JE, Jr. Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase. Mol Cell Biol 1997; 17: 6618-6623
30. Kojima H, Sasaki T, Ishitani T, et al. STAT3 regulates Nemo-like kinase by mediating its interaction with IL-6-stimulated TGFbeta-activated kinase 1 for STAT3 Ser-727 phosphorylation. Proc Natl Acad Sci USA 2005; 102: 4524-4529 (Pubitemid 40397145)
31. Lim CP, Cao X. Serine phosphorylation and negative regulation of Stat3 by JNK. J Biol Chem 1999; 274: 31055-31061 (Pubitemid 129576860)
32. Akira S. Stem Functional roles of STAT family proteins: lessons from knockout mice. Stem Cells 1999; 17:138-146 (Pubitemid 29226664)
33. Ihle JN. The Stat family in cytokine signaling. Curr Opin Cell Biol 2001; 13: 211-217
34. Reich NC. STAT3 revs up the powerhouse. Sci Signal 2009; 2: pe61.
35. Decker T, Kovarik P. Serine phosphorylation of STATs. Oncogene. 2000; 19: 2628-2637
36. Lufei C, Koh TH, Uchida T, Cao X. Pin1 is required for the Ser727 phosphorylation-dependent Stat3 activity. Oncogene 2007; 26: 7656-7664 (Pubitemid 350224213)
37. Aziz MH, Manoharan HT, Church DR, et al. Protein kinase C interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer. Cancer Res 2007; 67: 8828-8838
38. Androutsellis-Theotokis A, Leker RR, Soldner F, et al. Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 2006; 442: 823-826 (Pubitemid 44258913)
39. Liu H, Ma Y, Cole SM, et al. Serine phosphorylation of STAT3 is essential for Mcl-1 expression and macrophage survival. Blood 2003; 102: 344-352 (Pubitemid 36759675)
40. Wang J, Schreiber RD, Campbell IL. STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-alpha in the central nervous system. Proc Natl Acad Sci USA 2002; 99: 16209-16214 (Pubitemid 35462774)
41. Shen Y, Schlessinger K, Zhu X, et al. Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation. Mol Cell Biol 2004; 24: 407-419 (Pubitemid 38010065)
42. Duer MJ, Friscić T, Proudfoot D, et al. Mineral surface in calcified plaque is like that of bone: further evidence for regulated mineralization. Arterioscler Thromb Vasc Biol 2008; 28: 2030-2034
43. Parhami F, Demer LL. Arterialcalcification in face of osteoporosis in ageing: can we blame oxidized lipids? Curr Opin Lipidol 1997; 8: 312-314
44. Mohr W, Görz E. Calcifications in temporal arteries - their morphogenesis in comparison to physiological osteogenesis. Z Kardiol 2003; 92: 60-72. (Pubitemid 36197628)
45. Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 2006; 99: 1044-1059 (Pubitemid 44729928)
46. McGrath JC, Deighan C, Briones AM, et al. New aspects of vascular remodelling: the involvement of all vascular cell types. Exp Physiol 2005; 90: 469-475 (Pubitemid 40980147)
47. Speer MY, Yang HY, Brabb T, et al. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res 2009; 104: 733-741
48. Cola C, Almeida M, Li D, Romeo F, Mehta JL. Regulatory role of endothelium in the expression of genes affecting arterial calcification. Biochem Biophys Res Commun 2004; 320: 424-427 (Pubitemid 38798884)
49. Hruska KA, Mathew S, Lund RJ, Memon I, Saab G. The pathogenesis of vascular calcification in the chronic kidney disease mineral bone disorder: the links between bone and the vasculature. Semin Nephrol 2009; 29: 156-165
50. Milioti N, Bermudez-Fajardo A, Penichet ML, Oviedo-Orta E. Antigen-induced immunomodulation in the pathogenesis of atherosclerosis. Clin Dev Immunol 2008; 2008: 723539.
51. Collin-Osdoby P. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res 2004; 95: 1046-1057 (Pubitemid 39557891)
52. Guzman RJ. Clinical, cellular, and molecular aspects of arterial calcification. J Vasc Surg 2007; 45(Suppl A): A57-63.
53. Smith IO, Liu XH, Smith LA, Ma PX. Nanostructured polymer scaffolds for tissue engineering and regenerative medicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009; 1: 226-236
54. O'Brien KD, Kuusisto J, Reichenbach DD, et al. Osteopontin is expressed in human aortic valvular lesions. Circulation 1995; 92: 2163-2168
55. Azari F, Vali H, Guerquin-Kern JL, et al. Intracellular precipitation of hydroxyapatite mineral and implications for pathologic calcification. J Struct Biol 2008; 162: 468-479
56. Luo XH, Zhao LL, Yuan LQ, Wang M, Xie H, Liao EY. Adiponectin Regulates Arterial Calcification. J Bone Miner Res 2009; 24: 1461-1468
57. Palmer B, Watson LE, Riggs MW, et al. Comparison of lipid and non-lipid markers of atherosclerosis in arterial versus venous blood. Ann Clin Biochem 2003; 40: 286-288 (Pubitemid 36561005)
58. Bouletreau PJ, Warren SM, Spector JA, et al. Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. Plast Reconstr Surg 2002; 109: 2384-2397
59. Csiszar A, Lehoux S, Ungvari Z. Hemodynamic forces, vascular oxidative stress, and regulation of BMP-2/4 expression. Antioxid Redox Signal 2009; 11: 1683-1697
60. Csiszar A, Smith KE, Koller A, Kaley G, Edwards JG, Ungvari Z. Regulation of bone morphogenetic protein-2 expression in endothelial cells: role of nuclear factor-kappaB activation by tumor necrosis factor-alpha, H2O2, and high intravascular pressure. Circulation 2005; 111: 2364-2372
61. Zhang M, Zhou SH, Li XP, et al. Atorvastatin downregulates BMP-2 expression induced by oxidized low-density lipoprotein in human umbilical vein endothelial cells. Circ J 2008; 72: 807-812 (Pubitemid 351716687)
62. Wilkinson FL, Liu Y, Rucka AK, et al. Contribution of VCAF-positive cells to neovascularization and calcification in atherosclerotic plaque development. J Pathol 2007; 211: 362-369 (Pubitemid 46172712)
63. Matsumoto T, Kuroda R, Mifune Y, et al. Circulating endothelial/skeletal progenitor cells for bone regeneration and healing. Bone 2008; 43: 434-439
64. Somers P, Knaapen M, Kockx M, van Cauwelaert P, Bortier H, Mistiaen W. Histological evaluation of autophagic cell death in calcified aortic valve stenosis. J Heart Valve Dis 2006; 15: 43-47
65. Reed JC. Apoptosis and cell death. Foreword. Oncogene 2008; 27: 6192-6193
66. Srinivas V, Bohensky J, Zahm AM, Shapiro IM. Autophagy in mineralizing tissues: microenvironmental perspectives. Cell Cycle 2009; 8: 391-393
67. Li DD, Wang LL, Deng R, et al. The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells. Oncogene 2009; 28: 886-898
68. Kondo Y, Kondo S. Autophagy and cancer therapy. Autophagy 2006; 2: 85-90.
69. Chau BN, Wang JY. Coordinated regulation of life and death by RB. Nat Rev Cancer 2003; 3: 130-138
70. Tracy K, Dibling BC, Spike BT, Knabb JR, Schumacker P, Macleod KF. BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol Cell Biol 2007; 27: 6229-6242 (Pubitemid 47326709)
71. Millán JL. Alkaline Phosphatases: Structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes. Purinergic Signal 2006; 2: 335-341
72. Libby P. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 2008; 121: S21-31.
73. Caceres-Cortes JR. A potent anti-carcinoma and anti-acute myeloblastic leukemia agent, AG490. Anticancer Agents Med Chem 2008; 8: 717-722
74. Choi SC, Yoon J, Shim WJ, Ro YM, Lim DS. 5-azacytidine induces cardiac differentiation of P19 embryonic stem cells. Exp Mol Med 2004; 36: 515-523 (Pubitemid 40129173)
75. Zhang Q, Wang HY, Woetmann A, Raghunath PN, Odum N, Wasik MA. STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes. Blood 2006; 108: 1058-1064 (Pubitemid 44154645)
76. Han Y, Amin HM, Frantz C, et al. Restoration of shp1 expression by 5-AZA-2'-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma. Leukemia 2006; 20: 1602-1609 (Pubitemid 44264104)
77. Aguilar-Vázquez R, Carballo-Molina OA, Collazo-Navarrete O, et al. [Osteogenesis of human vascular endothelial cells in culture]. Rev Invest Clin 2008; 60: 496-501.
78. Fan J, Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb 2003; 10: 63-71.